U.S. PHYSICAL THERAPY INC (USPH) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:USPH - US90337L1089 - Common Stock
81 USD
+0.76 (+0.95%)
81 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to USPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 105.67. This target is 30.46% above the current price.
USPH was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about USPH.
In the previous month the buy percentage consensus was at a similar level.
USPH was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-07-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-12-16 | JMP Securities | Initiate | Market Outperform |
| 2024-12-16 | B of A Securities | Upgrade | Neutral -> Buy |
| 2024-12-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-21 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-07 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-09 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-07 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-15 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-09 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-03-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-01-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-11-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-11-09 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-09-22 | JP Morgan | Initiate | Overweight |
| 2023-09-19 | CJS Securities | Upgrade | Market Perform -> Market Outperform |
| 2023-08-14 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-06-30 | B of A Securities | Initiate | Buy |
| 2023-05-05 | Barrington Research | Maintains | Outperform |
| 2023-02-24 | Barrington Research | Maintains | Outperform |
| 2021-12-14 | CJS Securities | Upgrade | Market Perform -> Market Outperform |
| 2021-05-07 | Barrington Research | Upgrade | Market Perform -> Outperform |
U.S. PHYSICAL THERAPY INC / USPH FAQ
What is the average price target for U.S. PHYSICAL THERAPY INC (USPH) stock?
13 analysts have analysed USPH and the average price target is 105.67 USD. This implies a price increase of 30.46% is expected in the next year compared to the current price of 81.
How do analysts rate U.S. PHYSICAL THERAPY INC (USPH)?
The consensus rating for U.S. PHYSICAL THERAPY INC (USPH) is 84.6154 / 100 . This indicates that analysts generally have a positive outlook on the stock.